Articles Archives - Page 305 of 747

ThursdayApr 14, 2022 9:00 am

Advanced Container Technologies Inc.’s (ACTX) Grow Pods Offer Attractive Investment Option for Entry into Indoor Farming

Modular indoor farming is expected to grow to $9.7 billion worldwide by 2026 The “Times” reports that controlled-environment agriculture, including indoor farms, is attracting venture capitalists ACT’s Grow Pods are essentially micro-farms that can be placed anywhere and allow cultivation 365 days a year Modular indoor farms are expanding as the demand for year-round produce steadily increases, reports the “New York Times” last week (https://ibn.fm/Nnu3b). That upward swing is not news to Advanced Container Technologies (OTC: ACTX), a savvy company that has been pioneering the idea through the distribution of self-contained, automated, indoor micro-farms called Grow Pods. “Vertical farming is expected…

ThursdayApr 14, 2022 9:00 am

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Establishing Foothold in Growing REE Market

Recent report forecasts REE space to see 4% CAGR through 2027 Demand for magnets projected to increase demand for rare earth elements Energy Fuels is the only U.S. company producing an REE product this far down the REE supply chain A recent Mordor Intelligence article is reporting that the global rare earth elements (“REE”) market has reached an estimated 161,354.65 tons this year, with an expected compound annual growth rate (“CAGR”) of more than 4% between now and 2027 (https://ibn.fm/6UppN). That growth could prove beneficial to Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company…

ThursdayApr 14, 2022 9:00 am

Friendable Inc. (FDBL) Releases New Corporate Presentation with 2022 Goals; Highlights Positive Growth Metrics for March 2022

The company reported growth across multiple areas in March 2022, including number of customers and subscriptions, spend per customer and revenue per subscriber The Friendable 360 artist offering provides independent artists with multiple production, distribution, and marketing opportunities, as well as several ways to earn revenue The new corporate presentation details the upcoming NFT and virtual offering for artists to digitize their music Friendable (OTC: FDBL), a mobile technology and marketing company offering independent music artists control over their music through a 360 artist offering, has announced the release of a new corporate presentation that clearly outlines the company’s 2022…

WednesdayApr 13, 2022 9:30 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Introduces FDA-Approved SPRAVATO(R) Nasal Spray at KWC Clinics in a Move to Make Mental health Treatment Effective and Affordable

Ketamine Wellness Centers (“KWC”), a subsidiary of Delic Holdings, just expanded its treatment options to include SPRAVATO(R) nasal spray beginning April 1 SPRAVATO received FDA approval back in 2019 and would be used in conjunction with an oral antidepressant Its introduction to KWC clinics underscores the company’s commitment to providing clinically-backed, accessible and affordable treatments to patients nationwide Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), through its wholly-owned subsidiary, Delic Labs, has remained committed to expanding its ability to research novel compounds and developing intellectual property (“IP”) for future commercialization of novel psychedelic compounds for medical use. So far,…

WednesdayApr 13, 2022 9:30 am

O’Cannabiz Conference Expo & Awards Offering A Confluence Of Cannabis Industries

Cannabis enthusiasts, traders, cultivators and allied industries are invited to attend the O’Cannabis Expo & Awards from June 1-3, 2022 In Toronto, Canada. After the last year’s rescheduling, the O’Cannabis Conference is back this year for a physical 3-day event. The team is grateful to the exhibitors, sponsors, partners as well as pre-purchased ticket holders for their patience and trust. The event venue is the International Centre Hall #5, Toronto, Canada, a hub of business and consumer exhibitions in Canada. O’Cannabiz is a leading company engaged in organizing national high-profile events, to foster global connections between business houses and the…

WednesdayApr 13, 2022 9:15 am

GreenBox POS (NASDAQ: GBOX) Releases Fourth Quarter and Full Year 2021 Results

On March 31, GreenBox POS released the financial results for the three months (“Q4 FY 2021”) and full year (“FY2021”) ended December 31, 2021 Company achieved record revenue in 2021 of $26.3 million, an increase of $17.8 million or 208.6% from $8.5 million in 2020 The Q4 FY2021 results build on Q3 2021 figures in which the company reported year-over-year growth in both transaction volume and revenues The financial figures were accompanied by a corporate update and expected prospects for 2022. On Thursday, March 31, at 4.30 PM Eastern, investors, stakeholders, and the general public heard about the progress that…

WednesdayApr 13, 2022 9:15 am

InnerScope Hearing Technologies Inc. (INND) Ends 2021 on Right Foot, Set for a Dominant 2022

Over 31 million Americans have hearing loss but don’t utilize a hearing aid, primarily due to prohibitively high costs In the last 5 years, U.S. Presidents and Congress has demonstrated a strong commitment to making hearing aids affordable to all, including pressure on the FDA to complete changes now InnerScope has aggressively grown its business model through two key acquisitions and new sales channels that should lend to significant revenue growth as new regulations are put in place More than 38 million Americans have some degree of hearing loss. Sadly, due mostly to prohibitively high costs, only about 20% of…

WednesdayApr 13, 2022 9:00 am

European Regulatory Approvals Help CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Advance ‘Potentially Pivotal’ Study of Novel Brain Cancer Drug

Novel brain cancer drug developer CNS Pharmaceuticals is developing a proprietary pharmaceutical candidate called Berubicin for the treatment of glioblastoma multiforme (“GBM”) CNS has received Fast Track designation for Berubicin, which will allow the company more frequent communications with the FDA CNS has initiated a global potentially pivotal clinical trial to evaluate Berubicin in treating GBM and began dosing patients at sites scattered across several states last year, with numerous additional sites preparing to enroll patients in the coming months CNS is now reporting approval from regulatory authorities in Switzerland and France to proceed with recruiting patients there The study…

TuesdayApr 12, 2022 9:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX): A Review of Its Research Developments

Lexaria Bioscience, the global innovator behind DehydraTECH drug delivery technology, has continuously focused on research into its patented technology The company has conducted both in vitro testing and in vivo animal and human testing to evaluate the ability of DehydraTECH to improve the delivery of various APIs (active pharmaceutical ingredients) Lexaria has multiple other studies lined up aimed at building sufficient data to effect meaningful industry and/or regulatory progress and sustainable increases in valuation As it moves toward national and international implementation and commercialization of its patented DehydraTECH(TM) drug delivery technology, Lexaria Bioscience (NASDAQ: LEXX) is aware of the need…

Site Search

Company Search

Category: Articles

Advanced Container Technologies Inc.’s (ACTX) Grow Pods Offer Attractive Investment Option for Entry into Indoor Farming

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Establishing Foothold in Growing REE Market

Friendable Inc. (FDBL) Releases New Corporate Presentation with 2022 Goals; Highlights Positive Growth Metrics for March 2022

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Introduces FDA-Approved SPRAVATO(R) Nasal Spray at KWC Clinics in a Move to Make Mental health Treatment Effective and Affordable

O’Cannabiz Conference Expo & Awards Offering A Confluence Of Cannabis Industries

GreenBox POS (NASDAQ: GBOX) Releases Fourth Quarter and Full Year 2021 Results

InnerScope Hearing Technologies Inc. (INND) Ends 2021 on Right Foot, Set for a Dominant 2022

European Regulatory Approvals Help CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Advance ‘Potentially Pivotal’ Study of Novel Brain Cancer Drug

Lexaria Bioscience Corp. (NASDAQ: LEXX): A Review of Its Research Developments

Market Basics

Newsletter Publishers

Public Companies